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κ-Opioid Antagonist Libraries
A combinatorial library has been applied to the discovery of a ligands for the κ-opioid receptor
(J.B. Thomas et al., J. Med. Chem., 41, (1998), 5188-5197). Whilst µ-opioid antagonists have
been used for many years in the treatment of drug abuse, κ antagonists might provide a more
effective and longer-lasting treatment and novel agents provide an attractive target for drug
discovery. The library described in this publication was based on 3,4-dimethyl-4-(3-
hydroxyphenyl)piperidine (1), a pharmacophore known to give non-selective opioid activity,
and two other components, an N-substituted or unsubstituted Boc-protected amino acid and a
range of substituted aryl carboxylic acids in a parallel solution-phase approach.
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The 288 products contained within the library were screened in competitive binding against a
known selective κ-opioid ligand, and it was apparent that a few compounds demonstrated
significant inhibition of binding at 100nM. Of these, (3) was the most potent with a Ki value of
6.9 nM. This compound further demonstrated 57-fold selectivity over the µ-opioid receptor
and >824-fold selectivity over the δ-receptor. The authors speculate that the potency and
selectivity is dependent on the optimum size of the lipophilic isopropyl group, and that the 4-
hydroxy substituent is also essential for receptor affinity.
--------------------------------------------------------------------------------------------------------------
Optimisation of PPARγ Agonists
Type 2 diabetes, defined by high plasma glucose levels, peripheral insulin resistance and
insufficient insulin secretion is a widespread, debilitating disease. Recently, a group at Glaxo
identified the receptor for the thiazolidinedione class of antidiabetics. One example, the drug
rosiglitazone, binds to the nuclear receptor peroxisome proliferator-activated receptor γ
(PPARγ), and for other analogues there is a correlation between potency of binding to the
PPARγ receptor and in vivo antiglycemic activity. The Glaxo group have also described a
number of studies through which high-affinity ligands for the PPARγ receptor have been
discovered. Most recently, a paper describes the use of a combination of orthodox solution-
phase chemistry and solid-phase combinatorial chemistry to explore SAR around the lead
compound (4) (J.L. Collins et al., J. Med. Chem., 41, (1998), 5037-5054).
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In the solid-phase SAR work, the caesium carboxylate (5, R=H) was attached to 2-chlorotrityl
resin and Mitsunobu chemistry was employed to generate a range of aryl ethers. A total of 62
compounds were generated in parallel on solid-support, subsequently cleaved using 10% TFA
in methylene chloride and were isolated with purities ranging from 16% to 98%. Of the
products, six compounds demonstrated pKi values greater than 6, and these were advanced to
further biological assays.
--------------------------------------------------------------------------------------------------------------
Glycopeptide Libraries
A large number of biological processes including immune response, cellular adhesion,
inflammation and cancer cell metastasis are controlled by recognition of glycoconjugates. In
addition many viral, bacterial and parasitic infections are also mediated by the interaction of
glycoconjugates with protein receptors. Consequently, compounds that mimic carbohydrates
that can ameliorate these interactions have the potential for treating a range of diseases.
In the search for carbohydrate-based pharmaceuticals a novel one bead-one compound library
of glycopeptides has been prepared using a novel encoding method (P.M. St. Hilaire et al., J.
Am. Chem. Soc., 120, (1998), 13312-13320). The method, named encoded ladder synthesis, is
based on the ladder library method, where in each round of synthesis a small proportion (10%)
of the growing compound is capped with a carboxylic acid. This permits MALDI-TOF mass
spectrometric identification of the product compounds by analysis of the unique mixture of
terminated intermediates. This method has been extended by the use of a range of capping
groups related to the monomers being added. Specifically, instead of adding an Fmoc-amino
acid, the beads were also capped with a small proportion of the similarly reactive Boc-
protected amino acid. Release of the glycopeptides from the resin support using a photolytic
reaction generated 300,000 combinatorial library products tested as oligosaccharide mimics
for the Lathyrus odoratus lectin.
